Remdesivir Alanine D4 (Mixture of diastereomers)

Remdesivir is an antiviral drug that has been used to treat COVID-19 patients. It works by inhibiting the replication of the virus, thereby reducing the severity and duration of the illness. Remdesivir Alanine D4 is a mixture of diastereomers of Remdesivir. It is a stable isotopic labeled compound that is used in pharmacokinetic and metabolic studies of Remdesivir. Remdesivir Alanine D4 is administered intravenously, and it is metabolized in the liver by hydrolysis and phosphorylation. It has a half-life of about 1-2 hours, and it is eliminated from the body through the urine and feces. The use of Remdesivir Alanine D4 in clinical studies has helped researchers to understand the pharmacokinetics and metabolism of Remdesivir, which is essential in developing effective treatment regimens for COVID-19 patients. The chemical information of Remdesivir Alanine D4 is as follows: Its molecular formula is C27H35N6O8P, and its molecular weight is 622.6 g/mol. It is a white to off-white powder that is soluble in water and methanol. The compound is stable under normal conditions of storage and handling. However, it should be stored at -20°C to ensure maximum stability. In conclusion, Remdesivir Alanine D4 is a useful compound in the study of Remdesivir pharmacokinetics and metabolism. It is an essential tool in the development of effective treatment regimens for COVID-19 patients.